Literature DB >> 14194101

INHIBITION OF BACTERIAL GROWTH BY DRUGS OF THE MORPHINE SERIES.

E J SIMON.   

Abstract

The growth of Escherichia coli is reversibly inhibited by drugs of the morphine series. The order of inhibitory effectiveness for the drugs tested was levallorphan > levorphanol > dextrorphan > nalorphine > morphine. The synthetic analgesic, levorphanol, was studied in greater detail. Its effectiveness was found to be strongly dependent on the pH of the medium. Raising the pH of the medium provides a higher concentration of the neutral free base which is thought to diffuse across cell membranes more readily. However, considerations other than the rate of entry of drug into the cells must be of importance since an already established growth inhibition is promptly reversed upon lowering the pH of the medium. Two mutants of Escherichia coli with altered sensitivity to levorphanol were isolated.

Entities:  

Keywords:  BACILLUS SUBTILIS; DIPLOCOCCUS PNEUMONIAE; ESCHERICHIA COLI; GROWTH; HYDROGEN-ION CONCENTRATION; MORPHINE; NALORPHINE; NARCOTIC ANTAGONISTS; PHARMACOLOGY

Mesh:

Substances:

Year:  1964        PMID: 14194101     DOI: 10.1126/science.144.3618.543

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  6 in total

1.  Stimulation of the growth and respiration of a methylotrophic bacterium by morphine.

Authors:  J Romeo; M Scheraga; W W Umbreit
Journal:  Appl Environ Microbiol       Date:  1977-11       Impact factor: 4.792

2.  Bacteriological studies with morphine-like narcotics: relevance to narcotic actions in mammals?

Authors:  A D Wolfe; J G Olenick; F E Hahn
Journal:  Antimicrob Agents Chemother       Date:  1975-02       Impact factor: 5.191

3.  Inhibition by levorphanol and related drugs of amino acid transport by isolated membrane vesicles from Escherichia coli.

Authors:  M J Holland; E J Simon
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

Review 4.  Opioid receptors: some perspectives from early studies of their role in normal physiology, stress responsivity, and in specific addictive diseases.

Authors:  M J Kreek
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

5.  Use of polymyxin B, levallorphan, and tetracaine to isolate novel envelope mutants of Escherichia coli.

Authors:  J B Dame; B M Shapiro
Journal:  J Bacteriol       Date:  1976-08       Impact factor: 3.490

6.  The effects of the morphine analogue levorphanol on leukocytes. Metabolic effects at rest and during phagocytosis.

Authors:  N Wurster; P Elsbach; E J Simon; P Pettis; S Lebow
Journal:  J Clin Invest       Date:  1971-05       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.